Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers.

McCall AL.

Curr Diab Rep. 2007 Oct;7(5):329-32. No abstract available.

PMID:
18173964
2.

New options for drug treatment of obesity in patients with Type 2 diabetes.

Kennedy RL, Khoo EY.

Diabet Med. 2005 Sep;22 Suppl 4:23-6. No abstract available.

PMID:
16109016
3.
4.

Exenatide and rimonabant: new treatments that may be useful in the management of diabetes and obesity.

Green JB, Feinglos MN.

Curr Diab Rep. 2007 Oct;7(5):369-75. Review.

PMID:
18173970
5.

Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.

Hollander P.

Am J Med. 2007 Feb;120(2 Suppl 1):S18-28; discussion S29-32.

PMID:
17296341
6.

Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.

Sánchez-Reyes L, Fanghänel G, Yamamoto J, Martínez-Rivas L, Campos-Franco E, Berber A.

Clin Ther. 2004 Sep;26(9):1427-35.

PMID:
15531005
7.

Pharmacotherapy for obesity--promise and uncertainty.

Yanovski SZ.

N Engl J Med. 2005 Nov 17;353(20):2187-9. No abstract available.

PMID:
16291989
8.

Rimonabant in obese patients with type 2 diabetes.

Roberfroid D.

Lancet. 2007 Feb 17;369(9561):553; author reply 554-5. No abstract available.

PMID:
17307092
9.

Rimonabant in obese patients with type 2 diabetes.

Randall MD, Kendall DA, Bennett AJ, O'Sullivan SE.

Lancet. 2007 Feb 17;369(9561):555. No abstract available.

PMID:
17307094
10.

[Obesity in adults].

Suter PM, Kolyvanos NU, Käser L, Vetter W.

Praxis (Bern 1994). 2007 Oct 17;96(42):1617-24; quiz 1625-6. Review. German. No abstract available.

PMID:
17974121
11.

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF; RIO-Diabetes Study Group.

Lancet. 2006 Nov 11;368(9548):1660-72. Erratum in: Lancet. 2006 Nov 11;368(9548):1650.

12.

[Pharmacotherapy for weight loss in patients with type 2 diabetes].

Toubro S.

Ugeskr Laeger. 2007 Aug 13;169(33):2619-22. Danish. No abstract available.

PMID:
17725907
13.

Appetite downer awaits approval.

Wadman M.

Nature. 2005 Sep 29;437(7059):618-9. No abstract available.

PMID:
16193017
14.

[Reducing obesity].

Letonturier P.

Presse Med. 2006 Jan;35(1 Pt 1):77-8. French. No abstract available. Erratum in: Presse Med. 2006 Mar;35(3 Pt 1):447.

PMID:
16470949
15.

[Endocannabinoids receptor blocker lets tumble not only money. A drug against metabolic syndrome?].

Aumiller J.

MMW Fortschr Med. 2004 Nov 4;146(45):12. German. No abstract available.

PMID:
15581096
16.

Endogenous cannabinoids: a new target in the treatment of obesity.

Kirkham TC.

Am J Physiol Regul Integr Comp Physiol. 2003 Feb;284(2):R343-4. No abstract available.

17.

Does rimonabant pull its weight for type 2 diabetes?

Cleland SJ, Sattar N.

Lancet. 2006 Nov 11;368(9548):1632-4. No abstract available.

PMID:
17098066
18.

[In diabetes cannabinoid antagonist kills two birds with one stone].

[No authors listed]

MMW Fortschr Med. 2005 Sep 1;147(35-36):10. German. No abstract available.

PMID:
16180564
19.

[Pharmacology of cannabinoid receptors].

Le Fur G, Rinaldi-Carmona M, Barth F, Alexander J.

Bull Acad Natl Med. 2007 Apr-May;191(4-5):933-8; discussion 938-40. French.

PMID:
18225447
20.

Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.

Van Gaal LF, Caterson ID, Coutinho W, Finer N, Maggioni AP, Sharma AM, Torp-Pedersen C, Ge H, Moran SA, Shepherd GM, James WP; SCOUT Investigators.

Diabetes Obes Metab. 2010 Jan;12(1):26-34. doi: 10.1111/j.1463-1326.2009.01090.x. Epub 2009 Sep 16.

PMID:
19758358

Supplemental Content

Support Center